Information
-
Trademark
-
79311144
-
International Classifications
-
Filing Date
February 04, 2021
3 years ago
-
Transaction Date
January 31, 2024
9 months ago
-
Status Date
March 28, 2022
2 years ago
-
Published for Opposition Date
February 15, 2022
2 years ago
-
Location Date
January 11, 2022
2 years ago
-
Status Code
774
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
AGREDA, SAMANTHA LEIGH
-
Attorney Docket Number
EBLM068.003I
Attorney Name
STACEY HALPERN
Law Office Assigned Location Code
N50
-
Owners
Mark Drawing Code
5000
Mark Identification
TIGEN
Case File Statements
- GS0051: Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases
- GS0011: Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals
- GS0441: Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists
- GS0101: Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions
- GS0421: Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services
Case File Event Statements
-
12/31/2023 - 10 months ago
40 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
12/11/2023 - 10 months ago
39 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
11/8/2023 - 11 months ago
38 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
11/8/2023 - 11 months ago
37 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR
-
8/2/2022 - 2 years ago
36 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Type: CORN
-
6/5/2022 - 2 years ago
35 - CORRECTION TRANSACTION RECEIVED FROM IB
Type: CRCV
-
4/10/2022 - 2 years ago
34 - REFUSAL PROCESSED BY IB
Type: RFNT
-
3/28/2022 - 2 years ago
33 - OPPOSITION INSTITUTED NO. 999999
Type: OP.I
-
3/16/2022 - 2 years ago
32 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Type: OPNS
-
3/16/2022 - 2 years ago
31 - OPPOSITION NOTICE (IB REFUSAL) CREATED
Type: OPNC
-
3/15/2022 - 2 years ago
30 - OPPOSITION PAPERS RECEIVED AT TTAB
Type: OPPF
-
2/15/2022 - 2 years ago
29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
2/15/2022 - 2 years ago
28 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
2/14/2022 - 2 years ago
27 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
1/26/2022 - 2 years ago
26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
1/26/2022 - 2 years ago
25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
1/26/2022 - 2 years ago
24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
1/11/2022 - 2 years ago
23 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
1/11/2022 - 2 years ago
22 - ASSIGNED TO LIE
Type: ALIE
-
1/10/2022 - 2 years ago
21 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
1/10/2022 - 2 years ago
20 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
1/10/2022 - 2 years ago
19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
1/10/2022 - 2 years ago
18 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
1/10/2022 - 2 years ago
17 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
1/7/2022 - 2 years ago
16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
1/7/2022 - 2 years ago
15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
1/7/2022 - 2 years ago
14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Type: ECDR
-
1/7/2022 - 2 years ago
13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
1/7/2022 - 2 years ago
12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
1/7/2022 - 2 years ago
11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
10/4/2021 - 3 years ago
10 - REFUSAL PROCESSED BY IB
Type: RFNT
-
9/14/2021 - 3 years ago
9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
9/14/2021 - 3 years ago
8 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
9/14/2021 - 3 years ago
7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
9/13/2021 - 3 years ago
6 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/27/2021 - 3 years ago
5 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/20/2021 - 3 years ago
4 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
5/25/2021 - 3 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
5/21/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
5/20/2021 - 3 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR